Palatin Technologies revenues fall in Q4
The company has posted a net loss of $4.24m for the fourth quarter 2010, or $0.40 loss per diluted share, compared to net loss of $200,530, or $0.02loss
Vertex Pharmaceuticals and Genomics have agreed a four-year extension to their drug discovery partnership in a deal with a potential value exceeding $220m.
Under the partnership, Webmedx will fully integrate NLPI’s advanced natural language processing (NLP) software into their QualityAnalytics solution thereby expanding customers’ ability to mine discrete, structured data from